The Mutational Landscape out-of Circulating Tumor Tissues inside Several Myeloma

Nibourel O, Guihard S, Roumier C, Pottier N, Terre C, Paquet A beneficial, Peyrouze P, Geffroy S, Quentin S, Alberdi An excellent, Abdelali RB, Renneville A, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok MH. Copy-count research understood the prognostic ;31(3):555-564.

Mohamed Have always been, Balsat M, Koering C, Maucort-Boulch D, Boissel Letter, Payen-Homosexual L, Cheok Meters, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Tigaud We, Hayette S, Dumontet C, Cros Elizabeth, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet Yards, Ceraulo A beneficial, Mortreux F, Wattel Elizabeth. Leuk Res. 2017;-twenty-eight.

Mishima Y, Paiva B, Shi J, Playground J, Manier S, Takagi S, Massoud Meters, Perilla-Glen A beneficial, Aljawai Y, Huynh D, Roccaro Am, Sacco A beneficial, Capelletti M, Detappe Good, Alignani D, Anderson KC, Munshi NC, Prosper F, Lohr JG, Ha Grams, Freeman SS, Van Allen EM, Adalsteinsson Va, Michor F, San Miguel JF, Ghobrial I’m. 2017;19(1):218-224.

Minnema MC, Kimby E, DSa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis Elizabeth, Kremer S, Fitsiori A beneficial, Simon L, Davi F, Lunn Yards, Castillo JJ, Patterson CJ, Le Garff-Tavernier M, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Guideline towards the prognosis, medication and you can response standards having Bing-Neel syndrome. Haematologica. 2017;102(1):43-51.

Micol JB, Pastore A great, Inoue D, Duployez N, Kim Elizabeth, Lee South carolina, Durham BH, Chung Yr, Cho H, Zhang XJ, Yoshimi Good, Krivtsov An effective, Koche Roentgen, Solary Age, Sinha An excellent, Preudhomme C, Abdel-Wahab O. ASXL2 is essential having haematopoiesis and you will acts as a beneficial haploinsufficient tumour suppressor in the leukemia. Nat Commun. 2017;8:15429.

Phone Associate

Meunier Meters, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet Meters, Wang Y, Faure P, Szymanski Grams, Duployez Letter, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Park S. Activated oxygen kinds accounts manage NF-kappaB activation by the lowest dosage deferasirox within the erythroid progenitors out-of lowest risk myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524.

Manier S, Salem KZ, Playground J, Landau Weil, Getz G, Ghobrial I am. Genomic difficulty from numerous myeloma and its particular scientific effects. Nat Rev Clin Oncol. 2017;14(2):100-113.

Manier S, Powers JT, Sacco Good, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta Meters, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro Was, Daley GQ, Ghobrial I will be. The fresh new LIN28B/let-eight axis try a novel therapeutic pathway inside the multiple myeloma. Leukemia. 2017;31(4):853-860.

Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco A, Roccaro Are, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller Elizabeth, Trippa L, Ghobrial I will be. Prognostic character regarding releasing exosomal miRNAs into the numerous myeloma. Blood. 2017;129(17):2429-2436.

TET2 exon dos skipping are a different positive prognostic factor having cytogenetically typical acute myelogenous leukemia (AML): TET2 exon 2 skipping in the AML

Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brown Le, Grey Letter, Bradner J, Whitesell L, Porco JA, Jr., Ghobrial Im. Inhibiting brand new oncogenic interpretation system is an effectual healing strategy for the several myeloma. Sci Transl Med. 2017;9(389).

Magnez R, Thiroux B, Taront S, Segaoula Z, Quesnel B, Thuru X. PD-1/PD-L1 joining training playing with microscale thermophoresis. Sci Associate. 2017;7(1):17623.

Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe An effective, Dumezy F, Feuillard J, Genevieve F, Guerin Age, Man J, Jouault H, Lepelley P, Maynadie Yards, Solly F, Ballon OW, Preudhomme C, Baruchel An effective, Dombret H, Ifrah N, Bene MC. Prognostic worth of multicenter disperse cytometry harmonized investigations from limited residual state within the serious myeloblastic leukemia. Hematol Oncol. 2017.


No responses yet

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *